Skip to content

Hemodynamic Management in Women With SHS

Hemodynamic Management Target on Continuous Monitoring in Cesarean Delivery-A Randomized Controlled Trial in Patients With Supine Hypotensive Syndrome

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05341362
Enrollment
60
Registered
2022-04-22
Start date
2022-04-17
Completion date
2023-06-01
Last updated
2023-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Supine Hypotensive Syndrome

Keywords

supine hypotensive syndrome, cesarean delivery, spinal anesthesia, CSEA

Brief summary

Supine hypotensive syndrome often occurs following spinal anesthesia for cesarean delivery.In our study we base the regulation and drug administration both on the regular monitor and on a novel monitor which reflects upon the hemodynamic changes. Our aim is to observe whether the outcome of SHS patients with anesthesia management based on hemodynamic figures differs from those based on experience.

Interventions

PROCEDURELiDCOrapid

According to the illustration of the patient's hemodynamic figures shown on the LiDCOrapid monitor, we decide on the timing of the vasopressor administration. This group aims to maintain the cardiac output within a baseline range.

Sponsors

China Medical University, China
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
22 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiologists (ASA) Physical Status Classification II and had no significant cardiovascular, pulmonary, renal or endocrine disease, without contraindications to CSEA,and could be diagnosed as SHS according to the criteria.

Exclusion criteria

* Patients undergoing emergency CD, CD under general anesthesia or patients' refusal to participate, or multiple fetations.

Design outcomes

Primary

MeasureTime frameDescription
Umbilical arterial blood gas PH30minutesThe value is tested immediately after the blood sample is achieved after the infant is born.

Secondary

MeasureTime frameDescription
Discomfort Score1daywe explored a scoring system to quantify the SHS symptom scale from 0 to 8, score high means more symptoms of SHS occurred
total vasopressor dosage30 minutestotal vasopressor given during the time span between the operation began to the baby was delivered
Umbilical blood gas lactate30minutesThe value is tested immediately after the blood sample is achieved after the infant is born.
Time span2 hoursthe period between the operation began to the baby was delivered

Countries

China

Contacts

Primary ContactLi Yuqing
liyuqing1997@gmail.com86-15942019671

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026